Media Says Alkermes is "Circling The Drain"!

Discussion in 'Alkermes' started by anonymous, Feb 25, 2020 at 8:15 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest


  2. anonymous

    anonymous Guest

  3. anonymous

    anonymous Guest

    There is one chance, and one chance only...dump Pops and the top leadership. Only the investors can make that happen, because the board is unwilling. Hey Vanguard (Prime-Cap Fund), T. Rowe Price, Wellington, & Blackrock...are you guys listening? You own over 57% of this failing company. Force a change in leadership or watch the value of your holdings continue to evaporate. Act now!!
     
  4. anonymous

    anonymous Guest

  5. anonymous

    anonymous Guest

    Let's see company is doing shitty... insider buys stocks, sending message that things are "looking up" sounds like cheap tricks by Pops and his crew to lure in investors and then short them out!!! Then Pops sells another round of his shares and then we shall do it over again. Did I miss anything? Oh yeah having house address in another country helps saving some on taxes.
     
  6. anonymous

    anonymous Guest

    Papa Pops and his coterie trying to spin spin spin. They’re the original spin doctors. Hey pops try getting more women in leadership roles in your company.
     
  7. anonymous

    anonymous Guest

    Yet another five year low stock price! Keep up the good work Papa Pops!
     
  8. anonymous

    anonymous Guest

    He doesn’t care what any of us think. He has more money than God and could have retired long ago. It’s all about ego and the game for him and others like him. Employees are the least of his concern
     
  9. anonymous

    anonymous Guest

    The post above was written by an idiot. The article shows the independent director purchased a grand total of $136,000! Just over 10K shares. How that is supposed to manipulate the stock price is beyond me or anyone!! I hope the moron that posted it doesn't actually work here. If he or she does, we have big problems. Complete IDIOT.
     
  10. anonymous

    anonymous Guest


    I think you have it exactly right. However, like most plans hatched in our "C Suite", it failed. With the stock now well under $16.00 a share we are nearing a tipping point beyond which recovery will be impossible.
     
  11. anonymous

    anonymous Guest

    Wow....$13.99 a share as today's close. When we set a ten year low we don't mess around! How much did Pops make this year?
     
  12. anonymous

    anonymous Guest

    Can we make it to under $10 today?? Come on guys, sell so we can make our goal.
     
  13. anonymous

    anonymous Guest

    The broad market rebounds by over 5% today...and we sink by almost 5%. We'll be in single digits well before Memorial Day, and all but shuttered by Labor Day.
     
  14. anonymous

    anonymous Guest

  15. anonymous

    anonymous Guest

    What the heck? Starting to pi$$ me off.
     
  16. anonymous

    anonymous Guest

  17. anonymous

    anonymous Guest

    "What's past is prologue"...at least that's what the Bard said.

    Keeping that in mind I decided to look back and see our progress over the last year. One year ago today our stock was trading at $33.67. At the moment we are trading at less than half that. This is not just a snapshot in time but a clear and undeniable trend. The further back you go the more stark it is. In February of 2018 we were trading at $67.26, and that was AFTER we clawed our way back from the disastrous (and self-inflicted) 48 point crash in early 2016.

    Now we are all supposed to be delighted with a target stock price of $20. Wow, what a buying opportunity! Admittedly, that looks pretty good when you compare it to today's price of $16.58...but every now and then we should look back to see just how far we have fallen. Our management team never misses an opportunity to miss an opportunity. That is the one consistent fact of this company, in good times and in bad.

    Lucky for him, Papa Pops can now blame any problems with the stock on COVID 19. What was his excuse before that?
     
  18. anonymous

    anonymous Guest

    The Dow rises 600 points today and we fall over 10% to $14.40. I think the market has figured out that Alkermes hit its high water mark some time ago.

    Sad to say, but long term CORONA should (in a strange way) be good news for Alkermes. The anxiety of the lock-down and the economic downturn is clearly increasing mental health problems and addiction.

    For a company selling mental health and addiction drugs that should be good news; right? Not for us. First, we don't really have an anxiety drug, and schizophrenia may or may not get worse as a result of anxiety. In any event, the jury is in on Aristada, and the providers think of it as a "me too" drug. Don't look for market share to grow significantly there.

    But what about addiction? With that on the rise shouldn't the future look rosy for Vivitrol sales? Shouldn't we be capturing a larger market share when things get back to normal? No. Lots of "emergency" measures making it easier for patients to get induced on and stay on buprenorphine (usually without the requirement to show up for counselling) have been created, and will stay in effect after the CORONA epidemic is past. The feds are also loosening up restrictions on extended methadone take home medications. Add to that the high cost of Vivitrol and the disaster states are facing with their budgets and the states will have no motivation to grow the overall market share for Vivitrol.

    We also must recognize that over the last few years there has been a war of ideas between the harm reduction world and those who believe in abstinence based recovery. Anybody who is paying attention knows that we lost that war long ago. The current focus on public heath only makes that worse.

    We have to face facts that post CORONA we will have an even smaller share of the addiction medication market than we did a few months ago. That is part of the reality being reflected in our stock price.
     
  19. anonymous

    anonymous Guest

    Face the facts is correct. You are working or at
    Least employed and being paid for being quarantined. By a shit company? Absolutely! But be thankful for what you have got! Many are out of work. Our Sr Leadership is simply out of touch!
     
  20. anonymous

    anonymous Guest

    Let's also remember that before CORONA hit, the opiate epidemic was actually on the decline. If we could not grab a bigger share of the addiction medication market when the opiate epidemic was at the center of public attention we certainly can't do it now.

    Then there is the issue of the very short attention span of politicians and the public. Here (in succession) is what will occupy public attention in the next year:

    • First it will be all CORONA all the time, along with the related issues of lock-down vs reopening the economy, economic fall out, etc.
    • Next we will fixate on the election for a few months.
    • Finally (post election) it will either be doom and gloom over another four years of Trump, or all about rebuilding the country, the government. and the economy under Biden.
    These topics will suck all of the oxygen out of the room, and all the public money off the table. Essentially no one in the media or politics will focus on opiate addiction. All of this is very bad news for Alkermes as the buprenorphine juggernaut continues to move forward.